Riskpilot← Back to searchSign inGet full accessVärnamo Veterinärklinik AB
ABActiveOrg 5592709470Kalkstensvägen 7Veterinary activities · NACE 7500Est. 202010 employees
Revenue 2025
SEK 15,8M
+27% vs 2024
EBITDA margin
11.0%
+45% vs 2024
Equity ratio
22.0%
Financial strength
Net profit 2025
SEK 772K
+162% vs 2024
| Revenue | SEK 15,8M | +27% |
| EBITDA | SEK 1,7M | +45% |
| Net profit | SEK 772K | +162% |
| Total assets | SEK 5,3M | +0% |
| Equity | SEK 1,2M | +199% |
| Employees | 10 | — |
Legal name
Värnamo Veterinärklinik AB
Org number
5592709470
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
11 september 2020
Share capital
SEK 50 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Veterinärvård och därmed förenlig verksamhet.
Address
Kalkstensvägen 7
Email
anna@varnamoveterinarklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 782 | 5 854 | 8 498 | 12 475 | 15 837 |
| Staff expenses | — | — | −4 074 | — | — |
| EBITDA | 61 | 641 | 1 059 | 1 206 | 1 748 |
| Depreciation & amort. | −30 | −194 | −274 | −367 | −478 |
| EBIT | 31 | 447 | 785 | 839 | 1 270 |
| Net financials | — | −56 | −75 | −37 | 33 |
| Profit before tax | 0 | 63 | 567 | 376 | 974 |
| Tax | −0 | −14 | −83 | −81 | −202 |
| Net profit | 0 | 49 | 483 | 295 | 772 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 802 | 3 008 | 4 147 | 5 244 | 5 264 |
| Equity | 50 | 99 | 583 | 387 | 1 159 |
| Long-term debt | 450 | 1 319 | 1 029 | 740 | 136 |
| Short-term debt | 271 | 1 232 | 2 034 | 3 190 | 2 714 |
| Total debt | 721 | 2 551 | 3 063 | 3 930 | 2 850 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20212025
Equity ratio
22.0%
This company
38.2%
Market median
-42% vs market
20212025
Return on equity
66.6%
This company
18.4%
Market median
+262% vs market
20212025
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20212025
Asset turnover
3.01×
This company
1.12×
Market median
+169% vs market
20212025
Debt / equity
3.54×
This company
0.62×
Market median
-471% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DK | Audit | 2024 |
AM Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
LH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Värnamo Veterinärklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Karl Gunnar Johansson | Audit | 0 companies |
| Linnéa Haga | Deputy Chief Executive Officer | 0 companies |
| Anna Maria Nilsson | Chief Executive Officer | 0 companies |
| Per-Erik Joachim Schylström | Deputy Board Member | 0 companies |